Results 91 to 100 of about 5,207 (190)

Thoracoscopic resection for esophageal cancer: A review of literature

Journal of Minimal Access Surgery, 2007
Esophageal resection remains the only curative option in high grade dysplasia of the Barrett esophagus and non metastasized esophageal cancer. In addition, it may also be an adequate treatment in selected cases of benign disease.
Scheepers Joris, van der Peet Donald, Veenhof Alexander, Cuesta Miguel   +3 more
doaj  

Two Cancers in One Barrett’s Segment: First Report of Concurrent Squamous Cell Carcinoma and Adenocarcinoma

GE: Portuguese Journal of Gastroenterology, 2022
Vincent Zimmer, Bert Bier, Myriam Metzger, Matthias Glanemann   +3 more
doaj   +1 more source

A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer. [PDF]

Dig Dis Sci, 2022
Saller J, Jiang K, Xiong Y, Yoder SJ, Neill K, Pimiento JM, Pena L, Corbett FS, Magliocco A, Coppola D.   +9 more
europepmc   +1 more source

How are we measuring health-related quality of life in patients with a Barrett Esophagus? A systematic review on patient-reported outcome measurements. [PDF]

Qual Life Res, 2022
van der Ende-van Loon MCM, Stoker A, Nieuwkerk PT, Curvers WL, Schoon EJ.   +4 more
europepmc   +1 more source

Endoscopic biopsy techniques in Barrett esophagus patients: a multidesign study. [PDF]

Endoscopy
Beaufort IN, Elias SG, Akkerman EMP, Milne AN, Brosens LAA, Verhagen MAMT, Alvarez Herrero L, Weusten BLAM.   +7 more
europepmc   +1 more source

Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data. [PDF]

EClinicalMedicine, 2021
Swart N, Maroni R, Muldrew B, Sasieni P, Fitzgerald RC, Morris S, BEST3 Consortium.   +6 more
europepmc   +1 more source

Diagnostic Test Accuracy of Cytosponge-Trefoil Factor 3 for Barrett Esophagus: A Systemic Review and Meta Analysis. [PDF]

JGH Open
Kakar MT, Ramani AK, Kumar A, Lal A, Lohana DK, Radhika FNU, Mushtaq A, Shaikh S, Kamran R, Kumari J, Burhan M, Jawwad M, Riaz H.   +12 more
europepmc   +1 more source

Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus. [PDF]

Am J Gastroenterol
Laun SE, Laun SE, Kann L, Braun J, Gilbert S, Lunz D, Pierre F, Kalra A, Ma K, Tsai HL, Wang H, Jit S, Cheng Y, Ahmed Y, Wang KK, Leggett CL, Cellini A, Ioffe OB, Zaidi AH, Omstead AN, Jobe B, Korman L, Cornish D, Zellenrath P, Spaander M, Kuipers E, Perpetua L, Greenwald BD, Maddala T, Meltzer SJ.   +29 more
europepmc   +1 more source